Maynard M - Search Results

1

Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).

Fontaine H, Maynard M, Bouix C, Carrieri MP, Botta-Fridlund D, D'Alteroche L, Conti F, Pageaux GP, Leroy V, Métivier S, Anty R, Durand F, Canva V, Vilotitch A, Lebray P, Alric L, Duvoux C, Petrov-Sanchez V, Beaulieux F, Wellems C, Paul C, Roque-Afonso AM, Roche B, Pradat P, Samuel D, Duclos-Vallée JC; BOCEPRETRANSPLANT study group. Fontaine H, et al. Among authors: maynard m. Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):56-65. doi: 10.1016/j.clinre.2016.06.006. Epub 2016 Aug 20. Clin Res Hepatol Gastroenterol. 2017. PMID: 27554134

2

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.

Pradat P, Maynard M, Buti M, Berthillon P, Picchio G, Tillmann HL, Wiegand J, Voirin N, Manns MP, Esteban JI, Martinot M, Marcellin P, Trepo C. Pradat P, et al. Among authors: maynard m. J Med Virol. 2004 Jul;73(3):392-6. doi: 10.1002/jmv.20104. J Med Virol. 2004. PMID: 15170634

3

Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI).

Maynard M, Pradat P, Bailly F, Rozier F, Nemoz C, Si Ahmed SN, Adeleine P, Trépo C; French Multicenter Group. Maynard M, et al. J Hepatol. 2006 Mar;44(3):484-90. doi: 10.1016/j.jhep.2005.11.038. Epub 2005 Dec 20. J Hepatol. 2006. PMID: 16426697 Clinical Trial.

4

Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients.

Maynard M, Pradat P, Gagnieu MC, Souvignet C, Trepo C. Maynard M, et al. Antivir Ther. 2008;13(4):607-11. Antivir Ther. 2008. PMID: 18672540

5

Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus.

Ndongo N, Berthillon P, Pradat P, Vieux C, Bordes I, Berby F, Maynard M, Zoulim F, Trépo C, Petit MA. Ndongo N, et al. Among authors: maynard m. Hepatology. 2010 Nov;52(5):1531-42. doi: 10.1002/hep.23862. Hepatology. 2010. PMID: 20890942

6

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.

Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, Bonnefont-Rousselot D, Bastard JP, Rivière M, Spénard J; FRESGUN. Ratziu V, et al. Among authors: maynard m. J Hepatol. 2011 May;54(5):1011-9. doi: 10.1016/j.jhep.2010.08.030. Epub 2010 Oct 31. J Hepatol. 2011. PMID: 21145828 Clinical Trial.

7

Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.

Marcellin P, Arama V, Leblebicioglu H, Zarski JP, Zeuzem S, Mauss S, Sieklucki J, Acalovschi M, Usluer G, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Simon K; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Marcellin P, et al. Antivir Ther. 2014;19(3):235-43. doi: 10.3851/IMP2573. Epub 2013 Apr 10. Antivir Ther. 2014. PMID: 23574686

8

Pretreatment predictive factors for hepatitis C therapy outcome: relevance of anti-E1E2 antibodies compared to IP-10 and IL28B genotypes.

Arnaud C, Pradat P, Spaziante M, Berthillon P, Maynard M, Taliani G, Chemin I, Trépo C, Petit MA. Arnaud C, et al. Among authors: maynard m. Antivir Ther. 2013;18(8):1027-32. doi: 10.3851/IMP2671. Epub 2013 Aug 15. Antivir Ther. 2013. PMID: 23948510

9

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Carrieri MP, et al. J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24. J Hepatol. 2014. PMID: 23978720

10

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.

Hatu G, Bailly F, Pourcelot E, Pradat P, Miailhes P, Maynard M, Parant F, Chiarello P, Livrozet JM, Zoulim F, Gagnieu MC. Hatu G, et al. Among authors: maynard m. BMC Infect Dis. 2014 Mar 20;14:150. doi: 10.1186/1471-2334-14-150. BMC Infect Dis. 2014. PMID: 24650094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters